CorMedix Inc. (CRMD) › Cost of RevenueCorMedix Inc. (CRMD) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2012: $02013: -$201.6K2014: -$445.8K2015: -$318.7K2016: $366.7K2017: $115.0K2018: $396.8K2019: $373.2K2020: $204.8K2021: $148.9K2022: $3.7K2024: $3.03M2025: $22.09M$22.09M2012Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$22.09M+628.0%2024$3.03M—2022$3.7K-97.5%2021$148.9K-27.3%2020$204.8K-45.1%2019$373.2K-5.9%2018$396.8K+245.1%2017$115.0K-68.6%2016$366.7K+215.0%2015-$318.7K+28.5%2014-$445.8K-121.1%2013-$201.6K—2012$0—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share